• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Immunohistochemical quantitation of oestrogen receptors and proliferative activity in oestrogen receptor positive breast cancer.雌激素受体阳性乳腺癌中雌激素受体的免疫组化定量及增殖活性
J Clin Pathol. 1995 May;48(5):429-32. doi: 10.1136/jcp.48.5.429.
2
Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay.石蜡包埋乳腺癌组织中雌激素受体新免疫组织化学检测法与定量酶免疫测定法的比较
J Clin Pathol. 1994 Oct;47(10):900-5. doi: 10.1136/jcp.47.10.900.
3
Oestrogen receptor staining of paraffin-embedded breast carcinomas following short fixation in formalin: a comparison with cytosolic and frozen section receptor analyses.福尔马林短时间固定后石蜡包埋乳腺癌的雌激素受体染色:与胞质及冰冻切片受体分析的比较
J Pathol. 1990 Apr;160(4):295-303. doi: 10.1002/path.1711600405.
4
Immunoreactivity to MIB-1 in breast cancer: methodological assessment and comparison with other proliferation indices.乳腺癌中MIB-1的免疫反应性:方法学评估及与其他增殖指数的比较
Cell Prolif. 1997 Mar-Apr;30(3-4):107-15. doi: 10.1046/j.1365-2184.1997.00081.x.
5
Methodology of immunohistological detection of oestrogen receptor in human breast carcinoma in formalin-fixed, paraffin-embedded tissue: a comparison with frozen section methodology.福尔马林固定、石蜡包埋组织中人类乳腺癌雌激素受体免疫组织化学检测方法:与冰冻切片方法的比较
Histopathology. 1993 Sep;23(3):233-8. doi: 10.1111/j.1365-2559.1993.tb01195.x.
6
Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count.乳腺癌增殖活性评估:MIB-1免疫组织化学与有丝分裂计数对比
Hum Pathol. 1999 Nov;30(11):1314-20. doi: 10.1016/s0046-8177(99)90062-x.
7
Quantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast.MIB-1免疫反应性的定量图像分析。与乳腺浸润性癌增殖活性的流式细胞术评估的比较。
Anal Quant Cytol Histol. 1995 Feb;17(1):15-24.
8
Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma.浸润性乳腺癌雌激素受体免疫组化染色结果一致时所需的最短福尔马林固定时间。
Am J Clin Pathol. 2003 Jul;120(1):86-92. doi: 10.1309/QPHD-RB00-QXGM-UQ9N.
9
[Immunohistochemical detection of epidermal growth factor receptor (EGF-R) in paraffin sections of breast carcinoma tissue: correlation and clinical significance].[乳腺癌组织石蜡切片中表皮生长因子受体(EGF-R)的免疫组化检测:相关性及临床意义]
Geburtshilfe Frauenheilkd. 1995 May;55(5):258-65. doi: 10.1055/s-2007-1023314.
10
Estimation of the proliferative activity of human breast cancer tissue by means of the Ki-67 and MIB-1 antibodies--comparative studies on frozen and paraffin sections.借助Ki-67和MIB-1抗体评估人乳腺癌组织的增殖活性——冰冻切片与石蜡切片的对比研究
Virchows Arch. 1995;426(5):435-9. doi: 10.1007/BF00193164.

引用本文的文献

1
Reproducibility of microvessel counts in breast cancer specimens.乳腺癌标本中微血管计数的可重复性。
Br J Cancer. 1999 Nov;81(6):1088-93. doi: 10.1038/sj.bjc.6690811.
2
Quantitative histopathology in lymph node-negative breast cancer. Prognostic significance of mitotic counts.淋巴结阴性乳腺癌的定量组织病理学。有丝分裂计数的预后意义。
Virchows Arch. 1995;427(3):265-70. doi: 10.1007/BF00203393.

本文引用的文献

1
Proliferation index as a prognostic marker in breast cancer.
Cancer. 1993 Jun 15;71(12):3926-31. doi: 10.1002/1097-0142(19930615)71:12<3926::aid-cncr2820711221>3.0.co;2-2.
2
Improvement of the quantification of estrogen and progesterone receptors in paraffin-embedded tumors by image analysis.
Am J Clin Pathol. 1993 Jan;99(1):32-8. doi: 10.1093/ajcp/99.1.32.
3
The relevance of antibody concentration to the immunohistological quantification of cell proliferation-associated antigens.抗体浓度与细胞增殖相关抗原免疫组织化学定量的相关性。
Histopathology. 1993 Jun;22(6):543-7. doi: 10.1111/j.1365-2559.1993.tb00174.x.
4
Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score.通过增殖细胞核抗原评分预测乳腺癌患者的早期复发和生存期缩短
Cancer. 1993 Jun 1;71(11):3552-9. doi: 10.1002/1097-0142(19930601)71:11<3552::aid-cncr2820711115>3.0.co;2-n.
5
Intratumor variation in cell proliferation in breast carcinoma as determined by antiproliferating cell nuclear antigen monoclonal antibody and automated image analysis.通过抗增殖细胞核抗原单克隆抗体和自动图像分析确定的乳腺癌细胞增殖的肿瘤内异质性。
Am J Clin Pathol. 1993 Mar;99(3):226-31. doi: 10.1093/ajcp/99.3.226.
6
The influence of tissue processing on quantitative histopathology in breast cancer.
J Microsc. 1994 May;174(Pt 2):93-100. doi: 10.1111/j.1365-2818.1994.tb03453.x.
7
New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope.针对包含三个编码Ki-67表位的62个碱基对重复元件的Ki-67 cDNA细菌表达部分产生的新型Ki-67等效鼠单克隆抗体(MIB 1-3)。
Lab Invest. 1993 Jun;68(6):629-36.
8
Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.雌激素受体分析。使用单克隆抗受体抗体的生化方法与免疫组织化学方法的相关性。
Arch Pathol Lab Med. 1985 Aug;109(8):716-21.
9
Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables.通过Ki67免疫染色原位测定乳腺癌的增殖指数及其与临床和病理变量的关系。
J Pathol. 1987 Aug;152(4):287-95. doi: 10.1002/path.1711520407.
10
Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors.单克隆抗雌激素受体抗体在人类肿瘤免疫组织化学评估中的应用。
Cancer Res. 1986 Aug;46(8 Suppl):4244s-4248s.

雌激素受体阳性乳腺癌中雌激素受体的免疫组化定量及增殖活性

Immunohistochemical quantitation of oestrogen receptors and proliferative activity in oestrogen receptor positive breast cancer.

作者信息

Jensen V, Ladekarl M

机构信息

Institute of Pathology, Arhus Amtssygehus, Denmark.

出版信息

J Clin Pathol. 1995 May;48(5):429-32. doi: 10.1136/jcp.48.5.429.

DOI:10.1136/jcp.48.5.429
PMID:7629289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC502618/
Abstract

AIM

To evaluate the effect of the duration of formalin fixation and of tumour heterogeneity on quantitative estimates of oestrogen receptor content (oestrogen receptor index) and proliferative activity (MIB-1 index) in breast cancer.

METHODS

Two monoclonal antibodies, MIB-1 and oestrogen receptor, were applied to formalin fixed, paraffin wax embedded tissue from 25 prospectively collected oestrogen receptor positive breast carcinomas, using a microwave antigen retrieval method. Tumour tissue was allocated systematically to different periods of fixation to ensure minimal intraspecimen variation. The percentages of MIB-1 positive and oestrogen receptor positive nuclei were estimated in fields of vision sampled systematically from the entire specimen and from the whole tumour area of one "representative" cross-section.

RESULTS

No correlation was found between the oestrogen receptor and MIB-1 indices and the duration of formalin fixation. The estimated MIB-1 and oestrogen receptor indices in tissue sampled systematically from the entire tumour were closely correlated with estimates obtained in a "representative" section. The intra- and interobserver correlation of the MIB-1 index was good, although a slight systematical error at the second assessment of the intraobserver study was noted.

CONCLUSION

Quantitative estimates of oestrogen receptor content and proliferative activity are not significantly influenced by the period of fixation in formalin, varying from less than four hours to more than 48 hours. The MIB-1 and the oestrogen receptor indices obtained in a "representative" section do not deviate significantly from average indices determined in tissue samples from the entire tumour. Finally, the estimation of MIB-1 index is reproducible, justifying its routine use.

摘要

目的

评估福尔马林固定时间及肿瘤异质性对乳腺癌雌激素受体含量(雌激素受体指数)和增殖活性(MIB-1指数)定量评估的影响。

方法

采用微波抗原修复法,将两种单克隆抗体,即MIB-1和雌激素受体,应用于25例前瞻性收集的雌激素受体阳性乳腺癌的福尔马林固定、石蜡包埋组织。肿瘤组织被系统地分配到不同的固定时间段,以确保样本内变异最小。从整个标本以及一个“代表性”横截面的整个肿瘤区域系统采样的视野中,估计MIB-1阳性和雌激素受体阳性细胞核的百分比。

结果

未发现雌激素受体和MIB-1指数与福尔马林固定时间之间存在相关性。从整个肿瘤系统采样的组织中估计的MIB-1和雌激素受体指数,与在“代表性”切片中获得的估计值密切相关。MIB-1指数的观察者内和观察者间相关性良好,尽管在观察者内研究的第二次评估中发现了轻微的系统误差。

结论

福尔马林固定时间从不到4小时到超过48小时不等,其对雌激素受体含量和增殖活性的定量评估没有显著影响。在“代表性”切片中获得的MIB-1和雌激素受体指数与从整个肿瘤组织样本中确定的平均指数没有显著偏差。最后,MIB-1指数的估计具有可重复性,证明了其常规使用的合理性。